Report cover image

Sterile Injectables CMO Market - 2024-2033

Publisher DataM Intelligence 4Market Research LLP
Published May 29, 2025
Length 210 Pages
SKU # DTAM21122747

Description

Sterile Injectables CMO Market Overview:
The Sterile Injectables CMO Market was valued at US$ 14.12 Billion in 2024 and is anticipated to reach US$ 42.97 Billion by 2033, at a CAGR of 0.131 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Sterile Injectables CMO Market.

This report delivers a comprehensive overview of the Sterile Injectables CMO Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sterile Injectables CMO Market. The Sterile Injectables CMO Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Sterile Injectables CMO Market Scope:
Key Players
• Catalent, Inc

Major Highlights
This report delivers a comprehensive overview of the Sterile Injectables CMO Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sterile Injectables CMO Market. The Sterile Injectables CMO Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

210 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Packaging Material
2.5. Snippet by Formulation
2.6. Snippet by CMO Service Type
2.7. Snippet by CMO Therapeutic Area
2.8. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Increasing Investments and Development of New Products by Pharmaceutical Companies
3.1.1.2. Rising Demand for Biologics and Biosimilars
3.1.1.3. Increased Pharmaceutical R&D Investment
3.1.2. Restraints
3.1.2.1. High Manufacturing Costs
3.1.2.2. Challenges Related to Quality Control
3.1.2.3. Stringent Regulatory Requirements
3.1.3. Opportunity
4. Expansion in Emerging Markets
4.1. Growth in Large Molecule Segment
4.1.1. Impact Analysis
5. Strategic Insights and Industry Outlook
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with the largest-selling Brand
5.1.3. Market leaders with established Product
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics
6. Global Sterile Injectables CMO Market, By Product Type
6.1. Introduction
6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Small Molecule*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Cephalosporin
6.2.4. Penicillins
6.2.5. Carbapenems
6.2.6. Glycopeptides
6.2.7. Others
6.3. Large Molecule
6.3.1. Monoclonal Antibodies
6.3.2. Insulin
6.3.3. Immunoglobulin
6.3.4. Cytokines
6.3.5. Blood Factors
6.3.6. Others
7. Global Sterile Injectables CMO Market, By Packaging Material
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Material
7.1.2. Market Attractiveness Index, By Packaging Material
7.2. Vials*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ampoules
7.4. Prefilled Syringes
7.5. Others
8. Global Sterile Injectables CMO Market, By Formulation
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
8.1.2. Market Attractiveness Index, By Formulation
8.2. Powder*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Liquid
9. Global Sterile Injectables CMO Market, By CMO Service Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By CMO Service Type
9.1.2. Market Attractiveness Index, By CMO Service Type
9.2. Development Services*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Manufacturing Services
9.4. Packaging Services
9.5. Others
10. Global Sterile Injectables CMO Market, By Therapeutic Area
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
10.1.2. Market Attractiveness Index, By Therapeutic Area
10.2. Oncology*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cardiovascular Diseases
10.4. Central Nervous System Diseases
10.5. Infectious Disorders
10.6. Musculoskeletal Diseases
10.7. Hormonal Diseases
10.8. Others
11. Global Sterile Injectables CMO Market, By Regional Market Analysis and Growth Opportunities
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Material
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By CMO Service Type
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. U.S.
11.2.8.2. Canada
11.2.8.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Material
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By CMO Service Type
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. U.K.
11.3.8.3. France
11.3.8.4. Spain
11.3.8.5. Italy
11.3.8.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Material
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By CMO Service Type
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Brazil
11.4.8.2. Argentina
11.4.8.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Material
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By CMO Service Type
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. South Korea
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Material
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By CMO Service Type
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
12. Competitive Landscape and Market Positioning
12.1. Competitive Overview and Key Market Players
12.2. Market Share Analysis and Positioning Matrix
12.3. Strategic Partnerships, Mergers & Acquisitions
12.4. Key Developments in Product Portfolios and Innovations
12.5. Company Benchmarking
13. Company Profiles
13.1. Catalent, Inc*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
14. Financial Overview
14.1. Company Revenue
14.1.1. Geographical Revenue Shares
14.1.1.1. Revenue Forecasts
14.1.2. Key Developments
14.1.2.1. Mergers & Acquisitions
14.1.2.2. Key Product Development Activities
14.1.2.3. Regulatory Approvals, etc.
14.1.3. SWOT Analysis
15. Thermo Fisher Scientific Inc.
15.1. Samsung Biologics.
15.2. WuXi Biologics.
15.3. Lonza.
15.4. Recipharm AB.
15.5. Pfizer Inc.
15.6. Fresenius Kabi
15.7. Assia Chemical Industries Ltd
15.8. Aenova Holding GmbH (*LIST NOT EXHAUSTIVE)
16. Assumptions and Research Methodology
16.1. Data Collection Methods
16.2. Data Triangulation
16.3. Forecasting Techniques
16.4. Data Verification and Validation
17. Appendix
17.1. About Us and Services
17.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us